TCG Crossover
Venture Capital
Science-driven crossover fund investing in innovative private and public biotech companies developing transformative medicines.
Palo Alto, United States · 8+ investments · 19 portfolio companies
Early Stage
Growth
Late Stage
Public
Biotech
Healthcare
Life Sciences
- Headquarters
- Palo Alto, United States
- Founded
- 2021
- Website
- tcgcrossover.com
- AUM
- $3.1B
- Portfolio Companies
- 19
- Total Investments
- 8
- Last Investment
- May 2026
- Geographic Focus
- China, Europe, United States
Investment Thesis
Invests in visionary entrepreneurs leveraging scientific breakthroughs to develop transformative medicines, supporting companies across private and public markets with patient, closed-end capital at any lifecycle stage.
TCG Crossover is a Venture Capital firm based in Palo Alto, United States. It has made 8 investments in Biotech and Healthcare, including Korsana, Candid Therapeutics and Upstream Bio.
Portfolio19
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.